These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


224 related items for PubMed ID: 7199511

  • 1. The morphology of the human newborn ductus arteriosus: a reappraisal of its structure and closure with special reference to prostaglandin E1 therapy.
    Silver MM, Freedom RM, Silver MD, Olley PM.
    Hum Pathol; 1981 Dec; 12(12):1123-36. PubMed ID: 7199511
    [Abstract] [Full Text] [Related]

  • 2. Histopathology of the ductus arteriosus after prostaglandin E1 administration in ductus dependent cardiac anomalies.
    Gittenberger-de Groot AC, Moulaert AJ, Harinck E, Becker AE.
    Br Heart J; 1978 Mar; 40(3):215-20. PubMed ID: 637973
    [Abstract] [Full Text] [Related]

  • 3. Morphologic features of the ductus arteriosus after prostaglandin E1 administration for ductus-dependent congenital heart defects.
    Park IS, Nihill MR, Titus JL.
    J Am Coll Cardiol; 1983 Feb; 1(2 Pt 1):471-5. PubMed ID: 6681824
    [No Abstract] [Full Text] [Related]

  • 4. [Effects of prostaglandin in heart abnormalities with needed patency of the arterial canal (clinical and histological study)].
    Moulaert A, Gittenberger-De Groot A, Harinck E.
    Arch Fr Pediatr; 1978 Feb; 35(7):717-25. PubMed ID: 736728
    [Abstract] [Full Text] [Related]

  • 5. Prostaglandins and the management of congenital heart disease.
    Taylor WJ, Alpert BS.
    Am Fam Physician; 1982 Dec; 26(6):127-32. PubMed ID: 6890758
    [Abstract] [Full Text] [Related]

  • 6. Medical treatment of the ductus arteriosus.
    Rudolph AM, Heymann MA.
    Hosp Pract; 1977 Feb; 12(2):57-65. PubMed ID: 557025
    [Abstract] [Full Text] [Related]

  • 7. Congenital heart disease and respiratory distress syndrome. Reversal of indomethacin closure of patent ductus arteriosus by prostaglandin therapy in a preterm infant.
    Strauss A, Modanlou HD, Gyepes M, Wittner R.
    Am J Dis Child; 1982 Oct; 136(10):934-6. PubMed ID: 6889810
    [Abstract] [Full Text] [Related]

  • 8. Pathology of the ductus arteriosus treated with prostaglandins: comparisons with untreated cases.
    Calder AL, Kirker JA, Neutze JM, Starling MB.
    Pediatr Cardiol; 1984 Oct; 5(2):85-92. PubMed ID: 6591146
    [Abstract] [Full Text] [Related]

  • 9. Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease.
    Freed MD, Heymann MA, Lewis AB, Roehl SL, Kensey RC.
    Circulation; 1981 Nov; 64(5):899-905. PubMed ID: 7285305
    [No Abstract] [Full Text] [Related]

  • 10. Cardiovascular therapy in the newborn.
    Sandor GG.
    Clin Invest Med; 1985 Nov; 8(4):360-7. PubMed ID: 3907921
    [Abstract] [Full Text] [Related]

  • 11. Prostaglandins and the ductus arteriosus.
    Olley PM, Coceani F.
    Annu Rev Med; 1981 Nov; 32():375-85. PubMed ID: 7013675
    [Abstract] [Full Text] [Related]

  • 12. Human ductus arteriosus. A histological study on the relation between ductal maturation and gestational age.
    Tada T, Wakabayashi T, Nakao Y, Ueki R, Ogawa Y, Inagawa A, Shibata T, Kishimoto H.
    Acta Pathol Jpn; 1985 Jan; 35(1):23-34. PubMed ID: 4003093
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological manipulation of the ductus arteriosus.
    Silove ED.
    Arch Dis Child; 1986 Sep; 61(9):827-9. PubMed ID: 3767410
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of alprostadil (prostaglandin E1) in the management of congenital heart disease in infancy.
    Heymann MA, Clyman RI.
    Pharmacotherapy; 1982 Sep; 2(3):148-55. PubMed ID: 6763200
    [Abstract] [Full Text] [Related]

  • 15. Histopathology of the arterial duct (ductus arteriosus) with and without treatment with prostaglandin E1.
    Gittenberger-de Groot AC, Strengers JL.
    Int J Cardiol; 1988 May; 19(2):153-66. PubMed ID: 3372078
    [Abstract] [Full Text] [Related]

  • 16. Comments on the pharmacologic manipulation of the ductus arteriosus in newborns.
    Rowe RD.
    Adv Prostaglandin Thromboxane Res; 1978 May; 4():383-5. PubMed ID: 645513
    [No Abstract] [Full Text] [Related]

  • 17. Medical manipulation of the ductus arteriosus.
    Elliott RB, Starling MB, Neutze JM.
    Lancet; 1975 Jan 18; 1(7899):140-2. PubMed ID: 46053
    [Abstract] [Full Text] [Related]

  • 18. Transient neonatal tricuspid regurgitation: possible relation with premature closure of the ductus arteriosus.
    Berry TE, Muster AJ, Paul MH.
    J Am Coll Cardiol; 1983 Dec 18; 2(6):1178-82. PubMed ID: 6685153
    [Abstract] [Full Text] [Related]

  • 19. Use of prostaglandins in duct-dependent congenital heart conditions.
    Singh Y, Mikrou P.
    Arch Dis Child Educ Pract Ed; 2018 Jun 18; 103(3):137-140. PubMed ID: 29162633
    [Abstract] [Full Text] [Related]

  • 20. Prostaglandin and damage to ductus arteriosus.
    Moulaert AJ, Gittenberger AC, Harinck E.
    Lancet; 1977 Mar 26; 1(8013):703-4. PubMed ID: 66503
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.